Thrombelastography for the monitoring of lipopolysaccharide induced activation of coagulation

Thrombosis and Haemostasis

Volumn 95, Issue 3, 2006, Pages 557-561

  Zacharowski, Kai ^a   Sucker, Christoph ^a   Zacharowski, Paula ^a   Hartmann, Matthias ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Human whole blood; Lipopolysaccharide; Thrombelastography

Indexed keywords

BLOOD CLOTTING FACTOR 7A; CYCLOHEXIMIDE; LIPOPOLYSACCHARIDE; PROTEIN SYNTHESIS INHIBITOR; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEMOSTASIS; HUMAN; HUMAN CELL; LEUKOCYTE; MONITORING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; THROMBOCYTE POOR PLASMA; THROMBOELASTOGRAPHY; VOLUNTEER;

BLOOD COAGULATION; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKOCYTES; LIPOPOLYSACCHARIDES; PROTEIN SYNTHESIS INHIBITORS; REPRODUCIBILITY OF RESULTS; THROMBELASTOGRAPHY; THROMBOPLASTIN; WHOLE BLOOD COAGULATION TIME;

EID: 33645541191     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-06-0420     Document Type: Article

References (36)

1. Opal SM. Interactions between coagulation and inflammation. Scand J Infect Dis 2003; 35: 545-54.
2. Dempfle CE. Coagulopathy of sepsis. Thromb Haemost 2004; 91: 213-24.
3. Sabroe I, Read RC, Whyte MK, et al. Toll-like receptors in health and disease: complex questions remain. J Immunol 2003; 171: 1630-5.
4. Akira S. Toll-like receptor signaling. J Biol Chem 2003; 278: 38105-8.
5. Bernard GR, Vincent JL, Laterre PF, et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
6. Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989; 9: 2752-5.
7. Osterud B. Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagul Fibrinolysis 1998; 9 (Suppl 1): S9-14.
8. Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983; 49: 5-7.
9. Versteeg HH. Tissue factor as an evolutionary conserved cytokine receptor: Implications for inflammation and signal transduction. Semin Hematol 2004; 41 (Suppl 1): 168-72.
10. Giesen PL, Rauch U, Bohrmann B, et al. Bloodborne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
11. Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor: a circulating, soluble and thrombogenic protein. Nat Med 2003; 9: 458-62.
12. Roca M, Martin-Comin J, Becker M, et al. A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime. Eur J Nucl Med 1998; 25: 797-9.
13. Rippmann IF, Pfizenmaier K, Mattes R, et al. Fusion of the tissue factor extracellular domain to a tomour stroma specific single-chain fragment variable antibody results in an antigen-specific coagulation-promoting molecule. Biochem J 2000; 349: 805-12.
14. Petersen LC. Active-site inhibited seven: mechanism of action including signal transduction. Semin Hematol 2001; 38: 39-42.
15. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27: 1230-51.
16. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-92.
17. van Deventer SJ, Buller HR, ten Cate JW, et al. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76: 2520-6.
18. Taylor FB Jr. Role of tissue factor and factor VIIa in the coagulant and inflammatory response to LD100 Escherichia coli in the baboon. Haemostasis 1996; 26 (Suppl 1):83-91.
19. Herwald H, Morgelin M, Bjorck L. Contact activation by pathogenic bacteria: a virulence mechanism contributing to the pathophysiology of sepsis. Scand J Infect Dis 2003; 35: 604-7.
20. Wuillemin WA, Fijnvandraat K, Derkx BH, et al. Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock. Thromb Haemost 1995; 74: 1436-41.
21. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wschr 1948; 26: 577-83.
22. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001; 12: 327-37.
23. Whitten CW, Greilich PE. Thromboelastography: past, present, and future. Anesthesiology 2000; 92: 1223-5.
24. Samama CM. Thromboelastography: the next step. Anesth Analg 200 1; 92: 563-4.
25. Srinivasa V, Gilbertson LI, Bhavani-Shankar K. Thromboelastography: where is it and where is it heading? Int Anesthesiol Clin 2001; 39: 35-49.
26. Swennen ELR, Bast A, Dagnelie PC. Immunoregulatory effects of adenosine 5′-triphosphate on cytokine release from stimulated whole blood. Eur J Immunol 2005; 35: 852-8.
27. Nooteboom A, van der Linden J, Hendriks T. Tumor necrosis factor-a and interleukin-1ß mediate endothelial permeability induced by lipopolysaccharide-stimulated whole blood. Crit Care Med 2002; 30: 2063-8.
28. Poeschl JMB, Leray C, Ruef P, et al. Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro. Crit Care Med 2003; 31: 924-8.
29. Muehlstedt SG, Richardson CJ, Lyte M, et al. Systemic and pulmonary effector cell function after injury. Crit Care Med 2002; 30: 1322-6.
30. Dehoux MS, Hernot S, Asehnoune K, et al. Cardiopulmonary bypass decreases cytokine production in lipopolysaccharide-stimulated whole blood cells: Roles of interleukin-10 and the extracorporeal circuit. Crit Care Med 2000; 28: 1721-7.
31. Rittersma SZ, Kremer Hovinga JA, Koch KT, et al. Relationship between in vitro lipopolysaccharide-induced cytokine response in whole blood, angiographic in-stent restenosis, and TOLL-like receptor 4 gene polymorphisms. Clin Chem 2005; 51: 516-21.
32. Spolarics Z, Siddiqi M, Siegel JH, et al. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severly injured male trauma patients. Crit Care Med 2003; 31: 1722-9.
33. Souter PJ, Thomas S, Hubbard AR, et al. Anti-thrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med 2001; 29: 134-9.
34. Chabry R: Lipopolysaccharide-binding molecules: transporters, blockers and sensors. Cell Mol Life Sci 2004; 61: 1697-1713.
35. Warren HS, Novitsky TJ, Ketchum PA, et al. Neutralization of bacterial lipopolysaccharides by human plasma. J Clin Microbiol 1985; 22: 590-5.
36. Opal SM, Scannon PJ, Vincent JL, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Disease 1999; 180: 1584-9.